Medical Xpress July 31, 2024
A new artificial intelligence (AI) test to determine the risk of bowel cancers coming back could help patients avoid chemotherapy, according to new research led by the University of Leeds.
The work appears in the Journal of Clinical Oncology.
The test uses an AI algorithm to accurately assess the number of immune cells known as CD3 inside early-stage bowel cancer tumors. Bowel cancer, also known as colorectal cancer, is found anywhere in the large bowel, which includes the colon and rectum. It is one of the most common cancers in the world, with 1.9 million cases diagnosed in 2020.
In the study, the CD3 Score test reliably showed which stage II cancers were most likely to recur within five years...
Today's Sponsors
Today's Sponsor